HMOX1 and neoplasm: Both pharmacological suppression of HO-1 activity by zinc protoporphyrin IX (ZnPP-IX) or tin protoporphyrin IX (SnPP-IX) and targeted knockdown of HO-1 expression by siRNA significantly enhanced chemosensitivity in cancer cells and suppressed chemoresistant xenograft tumor growth in vivo.